# Ibex Medical Analytics awarded contracts to provide AI cancer diagnostics to 25 NHS Trusts

Ibex Medical Analytics received multiple contract awards from the PathLAKE consortium to provide AI-powered cancer diagnostics solutions for breast and prostate cancer to up to 25 NHS Trusts in the UK. Cambridge University Hospitals is one of the Trusts to select Ibex.

- Type: Contract
- Announced: 2023-03-07
- Where: United Kingdom
- Status: announced
- Products: AI-powered cancer diagnostics, breast cancer solutions, prostate cancer solutions
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Ibex Medical Analytics](https://endata.com/companies/57045.md) (supplier)
- [PathLAKE](https://endata.com/companies/69005.md) (customer)
- [Cambridge University Hospitals NHS Foundation Trust](https://endata.com/companies/69006.md) (customer)

## Sources

- [ibex-ai.com](https://ibex-ai.com/pathlake-contracts/), 2023-03-07: "The contract award follows a rigorous selection process which recognized Ibex as the top scoring solution provider for both the breast and prostate cancer categories, allowing up to 25 NHS Trusts to directly procure the Ibex breast and prostate solutions."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.